Title : Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways.

Pub. Date : 2020 Oct 1

PMID : 33019717






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways. Paclitaxel mitogen-activated protein kinase 8 Homo sapiens
2 According to the significant SAPK/JNK activation in PTX-res MCF-7 cells, specific c-Jun N-terminal kinase inhibitor, JNK-IN-8 is shown to suppress the migration potential of cells. Paclitaxel mitogen-activated protein kinase 8 Homo sapiens
3 However, the JNK inhibitor further downregulated Wnt signaling members in PTX-res MCF-7 cells. Paclitaxel mitogen-activated protein kinase 8 Homo sapiens
4 Therefore, the JNK inhibitor JNK-IN-8 might be used as a potential therapy model to reverse PTX-resistance related to Wnt signaling. Paclitaxel mitogen-activated protein kinase 8 Homo sapiens
5 Therefore, the JNK inhibitor JNK-IN-8 might be used as a potential therapy model to reverse PTX-resistance related to Wnt signaling. Paclitaxel mitogen-activated protein kinase 8 Homo sapiens